The first executive order requires that all policies and documents from federal agencies list two genders, male and female, ...

As always, federal employees and annuitants should carefully review their plan options this fall to ensure their FEHB plan continues to meet their needs.

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...

Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...

Medication-specific educational brochures promote patient engagement and deprescribing discussions between patients and their primary care providers, a recent study showed.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Scotland has become the first country in the UK to back NHS use of Eli Lilly’s obesity therapy Mounjaro, clearing it to assist weight management in eligible patients. The Scottish Medicines ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in ...